መነሻ › የዩዊንግ ሳርኮማ › ፍሎሪዳ
በፍሎሪዳ ለየዩዊንግ ሳርኮማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለየዩዊንግ ሳርኮማ የሚደረጉ 7 ጥናቶች በፍሎሪዳ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በፍሎሪዳ ውስጥ ያሉ ከተሞች
Official study text (English)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- University of Florida, Gainesville
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07194044Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
6 Months – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06395103Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 26 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 30 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06541262Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- St. Joseph's Children's Hospital, Tampa
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ0 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁላይ 2026 · NCT07321912Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- University of Florida, Gainesville
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
6 Months – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁን 2026 · NCT06625190Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Johns Hopkins All Children's Hospital, St. Petersburg
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ2 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ3 ፌብሩ 2026 · NCT05734066ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።